8-K
filed June 4, 2026, 7:28 PM ET
ticker GOSS
CIK 0001728117
debt
confidence high
sentiment neutral
materiality 0.85
Gossamer Bio, Inc. (GOSS): debt financing — Gossamer Bio exchanges 90.5% of 5% notes for new 7.5% notes, stock, and warrants
Gossamer Bio, Inc.
- $181M of 5% Convertible Senior Notes due 2027 tendered and cancelled (90.5% of outstanding).
- Issued $65M of new 7.5% Convertible Senior Secured First Lien Notes due 2030.
- Issued 254M common shares, 33.4M prefunded warrants, and 135.8M purchase warrants.
- Remaining $18.9M of existing notes outstanding; exchange offer open until June 16, 2026.
- Consent solicitation adopted amendments eliminating restrictive covenants in existing indenture.
Key facts
Extracted from this filing and checked against the source text.
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
Gossamer Bio, Inc. incurred convertible notes of $65,174,000 in aggregate principal amount of New Convertible Notes with U.S. Bank Trust Company, National Association at 7.50% per annum maturing July 1, 2030.
- Instrument
- convertible notes
- Principal
- $65,174,000 in aggregate principal amount of New Convertible Notes
- Counterparty
- U.S. Bank Trust Company, National Association
- Rate
- 7.50% per annum
- Maturity
- July 1, 2030
- Event
- incurrence
Exact text from the filing
the Company issued (i) $65,174,000 in aggregate principal amount of New Convertible Notes
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.95
Gossamer Bio, Inc. issued 135,789,000 Purchase Warrants of warrant to eligible holders of the Existing Convertible Notes for exchange of Existing Convertible Notes.
- Security
- warrant
- Shares
- 135,789,000 Purchase Warrants
- Purchaser
- eligible holders of the Existing Convertible Notes
- Consideration
- exchange of Existing Convertible Notes
Exact text from the filing
the Company issued $65,174,000 in aggregate principal amount of New Convertible Notes, 254,150,441 shares of its Common Stock, 33,402,727 Prefunded Warrants and 135,789,000 Purchase Warrants to eligible holders of the Existing Convertible Notes accepted for exchange in the Exchange Offer.
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.95
Gossamer Bio, Inc. issued convertible note to eligible holders of the Existing Convertible Notes for $65,174,000 in aggregate principal amount.
- Security
- convertible note
- Purchaser
- eligible holders of the Existing Convertible Notes
- Consideration
- $65,174,000 in aggregate principal amount
Exact text from the filing
the Company issued $65,174,000 in aggregate principal amount of New Convertible Notes, 254,150,441 shares of its Common Stock, 33,402,727 Prefunded Warrants and 135,789,000 Purchase Warrants to eligible holders of the Existing Convertible Notes accepted for exchange in the Exchange Offer.
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.95
Gossamer Bio, Inc. issued 33,402,727 Prefunded Warrants of warrant to eligible holders of the Existing Convertible Notes for exchange of Existing Convertible Notes.
- Security
- warrant
- Shares
- 33,402,727 Prefunded Warrants
- Purchaser
- eligible holders of the Existing Convertible Notes
- Consideration
- exchange of Existing Convertible Notes
Exact text from the filing
the Company issued $65,174,000 in aggregate principal amount of New Convertible Notes, 254,150,441 shares of its Common Stock, 33,402,727 Prefunded Warrants and 135,789,000 Purchase Warrants to eligible holders of the Existing Convertible Notes accepted for exchange in the Exchange Offer.
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.95
Gossamer Bio, Inc. issued 254,150,441 shares of common stock to eligible holders of the Existing Convertible Notes for exchange of Existing Convertible Notes.
- Security
- common stock
- Shares
- 254,150,441 shares
- Purchaser
- eligible holders of the Existing Convertible Notes
- Consideration
- exchange of Existing Convertible Notes
Exact text from the filing
the Company issued $65,174,000 in aggregate principal amount of New Convertible Notes, 254,150,441 shares of its Common Stock, 33,402,727 Prefunded Warrants and 135,789,000 Purchase Warrants to eligible holders of the Existing Convertible Notes accepted for exchange in the Exchange Offer.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Gossamer Bio, Inc. entered into Purchase Warrant Agreement with Computershare, Inc., as warrant agent (effective 2026-06-04).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- Computershare, Inc., as warrant agent
- Effective
- 2026-06-04
Exact text from the filing
a warrant agreement, dated as of June 4, 2026 (the “Purchase Warrant Agreement”), by and between the Company and Computershare, Inc., as warrant agent (the “Warrant Agent”).
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Gossamer Bio, Inc. entered into New Convertible Notes Indenture with U.S. Bank Trust Company, National Association, as trustee and collateral agent (effective 2026-06-04).
- Action
- entry
- Agreement
- notes offering
- Counterparty
- U.S. Bank Trust Company, National Association, as trustee and collateral agent
- Effective
- 2026-06-04
Exact text from the filing
an indenture, dated as of June 4, 2026 (the “New Convertible Notes Indenture”), by and between the Company, the guarantors party thereto and U.S. Bank Trust Company, National Association, as trustee and collateral agent (in such capacity, the “Collateral Agent”).
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.